ANI Pharma Reports Record Second Quarter And Year-To-Date 2017 Results And Reaffirms Guidance

BAUDETTE, Minn., Aug. 3, 2017 /PRNewswire/ --

For the second quarter 2017:

• Net revenues of $44.8 million, an increase of 43% as compared to the same period in 2016

• GAAP net income of $2.7 million and diluted GAAP earnings per share of $0.23